Short interest in Galectin Therapeutics Inc (NASDAQ:GALT) increased during the last reporting period, rising from 5.86M to 8.27M. This put 27.15% of the company's publicly available shares short.

Short interest for Galectin Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Galectin Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 811.17K shares traded per day, it would take 10.19 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.